Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.
Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
A Comparison of Amount and Speed of Deposition Between the PARI LC STAR® Jet Nebulizer and an Investigational eFlow® Nebulizer.
Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.
Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.
New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.